These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1507930)
1. Selenium: nutritional implications and prospects for therapeutic medicine. Fox JM Methods Find Exp Clin Pharmacol; 1992 May; 14(4):275-87. PubMed ID: 1507930 [No Abstract] [Full Text] [Related]
2. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Parnham MJ; Graf E Biochem Pharmacol; 1987 Oct; 36(19):3095-102. PubMed ID: 3311047 [No Abstract] [Full Text] [Related]
3. The pharmacology of ebselen. Parnham MJ; Leyck S; Graf E; Dowling EJ; Blake DR Agents Actions; 1991 Jan; 32(1-2):4-9. PubMed ID: 2058468 [No Abstract] [Full Text] [Related]
4. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds. Mishra B; Priyadarsini KI; Mohan H; Mugesh G Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452 [TBL] [Abstract][Full Text] [Related]
5. Effect of substituents on the GPx-like activity of ebselen: steric versus electronic. Pearson JK; Boyd RJ J Phys Chem A; 2008 Feb; 112(5):1013-7. PubMed ID: 18197644 [TBL] [Abstract][Full Text] [Related]
6. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions. Sarma BK; Mugesh G J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478 [TBL] [Abstract][Full Text] [Related]
7. Organochalcogen peroxidase mimetics as potential drugs: a long story of a promise still unfulfilled. Orian L; Toppo S Free Radic Biol Med; 2014 Jan; 66():65-74. PubMed ID: 23499840 [TBL] [Abstract][Full Text] [Related]
10. Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. Ip C; Lisk DJ; Ganther HE Anticancer Res; 2000; 20(6B):4179-82. PubMed ID: 11205245 [TBL] [Abstract][Full Text] [Related]
11. The synthesis of glutathione peroxidase analogs. Spector A; Wilson SR; Zucker PA; Huang RR; Raghavan PR Lens Eye Toxic Res; 1989; 6(4):773-80. PubMed ID: 2487281 [TBL] [Abstract][Full Text] [Related]
12. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Nogueira CW; Rocha JB Arch Toxicol; 2011 Nov; 85(11):1313-59. PubMed ID: 21720966 [TBL] [Abstract][Full Text] [Related]
13. Ebselen, a selenium-containing redox drug, releases zinc from metallothionein. Jacob C; Maret W; Vallee BL Biochem Biophys Res Commun; 1998 Jul; 248(3):569-73. PubMed ID: 9703967 [TBL] [Abstract][Full Text] [Related]
14. Development and Therapeutic Potential of Selenazo Compounds. Ruberte AC; Sanmartin C; Aydillo C; Sharma AK; Plano D J Med Chem; 2020 Feb; 63(4):1473-1489. PubMed ID: 31638805 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity, selenium levels, and glutathione peroxidase induction in A/J mice. Li L; Xie Y; El-Sayed WM; Szakacs JG; Roberts JC Life Sci; 2004 Jun; 75(4):447-59. PubMed ID: 15147831 [TBL] [Abstract][Full Text] [Related]
16. Chemical form of selenium, critical metabolites, and cancer prevention. Ip C; Hayes C; Budnick RM; Ganther HE Cancer Res; 1991 Jan; 51(2):595-600. PubMed ID: 1824684 [TBL] [Abstract][Full Text] [Related]
17. Biological activities and clinical potential of Ebselen. Parnham MJ Adv Exp Med Biol; 1990; 264():193-7. PubMed ID: 2244495 [No Abstract] [Full Text] [Related]
18. Ebselen decreases oxygen free radical production and iron concentrations in the hearts of chronically iron-overloaded mice. Davis MT; Bartfay WJ Biol Res Nurs; 2004 Jul; 6(1):37-45. PubMed ID: 15186706 [TBL] [Abstract][Full Text] [Related]
19. The effect of selenium compounds (selenite, selenate, ebselen) on the production of thromboxane and prostacyclin by the human term placenta in vitro. Eisenmann CJ; Miller RK Toxicol Appl Pharmacol; 1995 Nov; 135(1):18-24. PubMed ID: 7482536 [TBL] [Abstract][Full Text] [Related]
20. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. Salom JB; Pérez-Asensio FJ; Burguete MC; Marín N; Pitarch C; Torregrosa G; Romero FJ; Alborch E Eur J Pharmacol; 2004 Jul; 495(1):55-62. PubMed ID: 15219820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]